BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18616658)

  • 1. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
    Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
    Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
    Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
    Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
    Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.
    Kamm MA; Müller-Lissner S; Talley NJ; Tack J; Boeckxstaens G; Minushkin ON; Kalinin A; Dzieniszewski J; Haeck P; Fordham F; Hugot-Cournez S; Nault B
    Am J Gastroenterol; 2005 Feb; 100(2):362-72. PubMed ID: 15667494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
    Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
    Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tegaserod in chronic constipation in men.
    Fried M; Johanson JF; Gwee KA; Wagner A; Pecher E; Rueegg P
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
    Quigley EM; Wald A; Fidelholtz J; Boivin M; Pecher E; Earnest D
    Clin Gastroenterol Hepatol; 2006 May; 4(5):605-13. PubMed ID: 16678076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome.
    Nyhlin H; Bang C; Elsborg L; Silvennoinen J; Holme I; Rüegg P; Jones J; Wagner A
    Scand J Gastroenterol; 2004 Feb; 39(2):119-26. PubMed ID: 15000272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
    Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: tegaserod for chronic constipation.
    Johanson JF
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():20-4. PubMed ID: 15521851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the placebo response in functional dyspepsia.
    Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
    Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
    Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
    Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tegaserod use in children: a single-center experience.
    Liem O; Mousa HM; Benninga MA; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):54-8. PubMed ID: 18162834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.